<SEC-DOCUMENT>0001493152-25-004292.txt : 20250130
<SEC-HEADER>0001493152-25-004292.hdr.sgml : 20250130
<ACCEPTANCE-DATETIME>20250130171052
ACCESSION NUMBER:		0001493152-25-004292
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20250130
DATE AS OF CHANGE:		20250130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enveric Biosciences, Inc.
		CENTRAL INDEX KEY:			0000890821
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				954484725
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-284277
		FILM NUMBER:		25574821

	BUSINESS ADDRESS:	
		STREET 1:		4851 TAMIAMI TRAIL N, SUITE 200
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34103
		BUSINESS PHONE:		239-302-1707

	MAIL ADDRESS:	
		STREET 1:		4851 TAMIAMI TRAIL N, SUITE 200
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMERI Holdings, Inc.
		DATE OF NAME CHANGE:	20150527

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SPATIALIZER AUDIO LABORATORIES INC
		DATE OF NAME CHANGE:	19950323
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
filed with the Securities and Exchange Commission on January 30, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
Statement No. 333-284277</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment
No. 2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>UNDER</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>THE
SECURITIES ACT OF 1933</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Enveric
Biosciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2834</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>95-4484725</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State or other jurisdiction
    of</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Primary Standard Industrial</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S. Employer</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation or organization)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Classification Code Number)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification Number)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4851
Tamiami Trail N, Suite 200</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Naples,
FL 34103</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(239)
302-1707</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address,
including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Joseph
Tucker</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief
Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Enveric
Biosciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4851
Tamiami Trail N, Suite 200</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Naples,
FL 34103</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(239)
302-1707</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name,
address, including zip code, and telephone number, including area code, of agent for service)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bradley
    J. Wyatt, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rasika
    A. Kulkarni, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dickinson
    Wright PLLC</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1850
    N. Central Avenue Suite 1400</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Phoenix,
    AZ 85004</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(734)
    623-1905</B></FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Robert
    F. Charron</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ellenoff
    Grossman &amp; Schole LLP<BR>
    1345 Avenue of the Americas<BR>
    New York, New York 10105<BR>
    (212) 370-1300</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public:</B> As soon as practicable after the effective date of this Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Securities Exchange Act. (Check
one):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated
    filer </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date
as the Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPLANATORY
NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sole purpose of this Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-284277) (the &ldquo;Registration Statement&rdquo;)
is to file Exhibits 1.1, 1.2, and 23.2 as indicated in Item 16(a) of Part II of this amendment. No change is made to the
preliminary prospectus constituting Part I of the Registration Statement or Items 13, 14, 15 or 17 of Part II of the Registration Statement.
Accordingly, this amendment consists only of the cover page, this explanatory note, Item 16(a) of the Registration Statement, the exhibit
index to the Registration Statement, the signature page to the Registration Statement, and the exhibits filed herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
16. Exhibits and Financial Statement Schedules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exhibits - Our audited financial statements are included in the preliminary prospectus.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex1-1.htm">Engagement Letter between Enveric Biosciences, Inc. and H.C. Wainwright &amp; Co., LLC dated December 8, 2024 (&ldquo;Wainwright Engagement Letter&rdquo;)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex1-2.htm">Amendment to the Wainwright Engagement Letter, dated January 14, 2025</A></FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000114036120000667/ex2_1.htm" STYLE="-sec-extract: exhibit">Share Purchase Agreement, dated January 10, 2020, by and between AMERI Holdings, Inc. and Ameri100, Inc. (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 13, 2020)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315220015383/ex10-1.htm" STYLE="-sec-extract: exhibit">Tender Offer Support Agreement and Termination of Amalgamation Agreement, dated August 12, 2020, by and among AMERI Holdings, Inc., Jay Pharma Merger Sub, Inc., Jay Pharma Inc., 1236567 B.C. Unlimited Liability Company and Barry Kostiner, as the Ameri representative (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on August 12, 2020)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315220023958/ex10-1.htm" STYLE="-sec-extract: exhibit">Amendment No. 1 To Tender Offer Support Agreement and Termination of Amalgamation Agreement, dated December 18, 2020, by and among Ameri, Jay Pharma Merger Sub, Inc., Jay Pharma Inc., 1236567 B.C. Unlimited Liability Company and Barry Kostiner, as the Ameri representative (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on December 18, 2020)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221012752/ex2-1.htm" STYLE="-sec-extract: exhibit">Amalgamation Agreement, dated May 24, 2021, by and among Enveric Biosciences, Inc., 1306432 B.C. LTD., 1306436 B.C. LTD., and MagicMed Industries, Inc. (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on May 24, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000336/ex3-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Certificate of Incorporation of Enveric Biosciences, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000336/ex3-2.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Enveric Biosciences, Inc. (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000336/ex3-3.htm" STYLE="-sec-extract: exhibit">Certificate of Designations of Series B Preferred Stock of Enveric Biosciences, Inc. (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000336/ex3-4.htm" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of Enveric Biosciences, Inc. (incorporated by reference to Exhibit 3.4 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/ex3-1.htm" STYLE="-sec-extract: exhibit">Amendment to the Amended and Restated Bylaws of Enveric Biosciences, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on November 18, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222012076/ex3-1.htm" STYLE="-sec-extract: exhibit">Certificate of Designation of the Series C Preferred Stock of the Company, dated May 4, 2022 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Registration Statement on Form 8-A, filed with the Securities and Exchange Commission on May 4, 2022, File No. 000-26460)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222014217/ex3-2.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment of Certificate of Designation of the Series C Preferred Stock of the Company, dated May 17, 2022 (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Registration Statement on Form 8-A/A, filed with the Securities and Exchange Commission on May 17, 2022, File No. 000 26460)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222019341/ex3-1.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment of Amended and Restated Certificate of Incorporation of Enveric Biosciences, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 14, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225003091/ex3-1.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment of Amended and Restated Certificate of Incorporation of Enveric Biosciences, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 21, 2025)</A></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315223010431/ex4-1.htm" STYLE="-sec-extract: exhibit">Description of Securities (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 31, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000824/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Pre-Funded Warrant (issued in connection with January 2021 Registered Direct Offering) (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 12, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000824/ex4-2.htm" STYLE="-sec-extract: exhibit">Form of Warrant (issued in connection with January 2021 Registered Direct Offering) (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 12, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221003373/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Warrant (issued in connection with February 2021 Registered Direct Offering) (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on February 11, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221007757/ex4-5.htm" STYLE="-sec-extract: exhibit">Form of Series B Warrant (incorporated by reference to Exhibit 4.5 to the Company&#8217;s Annual Report on Form 10-K filed with the Commission on April 1, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221022964/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of MagicMed Warrant Certificate (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 17, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222004649/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Purchase Warrant (in connection with February 2022 Offering) (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on February 15, 2022)</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of RD Pre-Funded Warrant (in connection with July 2022 Offering) (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex4-2.htm" STYLE="-sec-extract: exhibit">Form of PIPE Pre-Funded Warrant (in connection with July 2022 Offering) (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex4-3.htm" STYLE="-sec-extract: exhibit">Form of RD Preferred Investment Option (in connection with July 2022 Offering) (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex4-4.htm" STYLE="-sec-extract: exhibit">Form of PIPE Preferred Investment Option (in connection with July 2022 Offering) (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex4-5.htm" STYLE="-sec-extract: exhibit">Form of Wainwright Warrant (in connection with July 2022 Offering) (incorporated by reference to Exhibit 4.5 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315223046601/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Inducement Warrant (in connection with December 2023 Offering) (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on December 29, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex4-14.htm" STYLE="-sec-extract: exhibit">Form of Pre-Funded Warrant offered hereby</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex4-15.htm" STYLE="-sec-extract: exhibit">Form of Series A Warrant offered hereby</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">4.16**</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex4-16.htm" STYLE="-sec-extract: exhibit">Form of Series B Warrant offered hereby</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex4-17.htm" STYLE="-sec-extract: exhibit">Form of Placement Agent Warrant</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion of Dickinson Wright PLLC</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1#</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315223006267/ex10-1.htm" STYLE="-sec-extract: exhibit">Employment Agreement between Kevin Coveney and the Company, effective March 13, 2023 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on February 28, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222012822/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement (entered into in connection with the May 5, 2022 Private Placement) (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on May 11, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222012822/ex10-2.htm" STYLE="-sec-extract: exhibit">Certificate of the Designations, Preferences and Rights of Akos Series A Convertible Preferred Stock (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on May 11, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222012822/ex10-3.htm" STYLE="-sec-extract: exhibit">Form of Registration Rights Agreement (entered into in connection with the May 5, 2022 Private Placement) (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on May 11, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222012822/ex10-4.htm" STYLE="-sec-extract: exhibit">Form of Warrant (entered into in connection with the May 5, 2022 Private Placement) (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on May 11, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex10-4.htm" STYLE="-sec-extract: exhibit">Form of Warrant Amendment (in connection with the July 2022 Offerings) (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222019341/ex10-1.htm" STYLE="-sec-extract: exhibit">First Amendment to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 14, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex10-4.htm" STYLE="-sec-extract: exhibit">Form of Warrant Amendment (in connection with July 2022 Offering) (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement (in connection with July 2022 Offering) (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement (in connection with July 2022 Offering) (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315222020362/ex10-3.htm" STYLE="-sec-extract: exhibit">Form of Registration Rights Agreement (in connection with July 2022 Offering) (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on July 26, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000336/ex10-5.htm" STYLE="-sec-extract: exhibit">Enveric Biosciences, Inc. 2020 Long-Term Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000336/ex10-6.htm" STYLE="-sec-extract: exhibit">Form of RSU Award Agreement (incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000824/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated January 11, 2021, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 12, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000824/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Registration Rights Agreement, dated January 11, 2021, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 12, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221000824/ex10-3.htm" STYLE="-sec-extract: exhibit">Letter Agreement, dated January 11, 2021, by and between the Company and Alpha Capital Anstalt (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on January 12, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221003373/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated February 9, 2021, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on February 11, 2021)</A></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221003373/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Registration Rights Agreement, dated February 9, 2021, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on February 11, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221011946/ex10-6.htm" STYLE="-sec-extract: exhibit">Exclusive License Agreement, between the Company and Diverse Biotech, Inc., dated March 5, 2021 (incorporated by reference to Exhibit 10.6 the Company&#8217;s Quarterly Report on Form 10-Q, filed with the Commission on May 17, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221018886/form424b3.htm#o_153" STYLE="-sec-extract: exhibit">Form of Voting and Support Agreement, dated as of May 24, 2021, by and among Enveric Biosciences, Inc. and certain shareholders of MagicMed Industries Inc. named therein (incorporated by reference to Annex B-1 to the Company&#8217;s Proxy Statement/Prospectus, filed with the Commission on August 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221018886/form424b3.htm#o_154" STYLE="-sec-extract: exhibit">Form of Voting Agreement, dated as of May 24, 2021, by and among MagicMed Industries Inc. and certain shareholders of Enveric Biosciences, Inc. named therein (incorporated by reference to Annex B-2 to the Company&#8217;s Proxy Statement/Prospectus, filed with the Commission on August 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221018886/form424b3.htm#ct_002" STYLE="-sec-extract: exhibit">Form of Lock-Up Agreement, dated as of May 24, 2021, by and among Enveric Biosciences, Inc. and certain shareholders of MagicMed Industries Inc. named therein (incorporated by reference to Annex C-1 to the Company&#8217;s Proxy Statement/Prospectus, filed with the Commission on August 6, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221018467/forms-4a.htm#ct_001" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Lock-Up/Leak-Out Agreement, dated as of May 24, 2021, by and among Enveric Biosciences, Inc. and certain shareholders of MagicMed Industries Inc. named therein (incorporated by reference to Annex C-2 to the Company&#8217;s Proxy Statement/Prospectus, filed with the Commission on August 3, 2021)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24#</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221012752/ex10-1.htm" STYLE="-sec-extract: exhibit">Employment Agreement between Joseph Tucker and Enveric Biosciences, Inc. (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25#</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221012752/ex10-2.htm" STYLE="-sec-extract: exhibit">Employment Agreement between Peter Facchini and Enveric Biosciences, Inc. (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26#</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221012752/ex10-3.htm" STYLE="-sec-extract: exhibit">Employment Agreement between Jillian Hagel and Enveric Biosciences, Inc. (incorporated by reference to Exhibit 10.3 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315221022964/ex10-1.htm" STYLE="-sec-extract: exhibit">MagicMed Stock Option Plan, as amended September 10, 2021 (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 17, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315223039443/ex10-1.htm" STYLE="-sec-extract: exhibit">Purchase Agreement, dated November 3, 2023, by and among the Company and Lincoln Park Capital Fund, LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed with the Commission on November 6, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315223039443/ex10-2.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated November 3, 2023, by and among the Company and Lincoln Park Capital Fund, LLC (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K, filed with the Commission on November 6, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30&#94;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315223046601/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Inducement Warrant, dated December 28, 2023, by and among the investors thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on December 29, 2023)</FONT></A></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315224009485/ex10-1.htm" STYLE="-sec-extract: exhibit">Form
    of Common Stock Purchase Agreement, dated March 8, 2024, between Enveric Biosciences, Inc. and the investors set forth therein
    (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission
    on March 11, 2024)</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315224017748/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Purchase Agreement, dated May 3, 2024, between Enveric Biosciences, Inc. and the investors set forth therein (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed with the Commission on May 3, 2024)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">10.33**</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><P STYLE="margin: 0"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex10-33.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement</A></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315223010431/ex21-1.htm" STYLE="-sec-extract: exhibit">Subsidiaries (incorporated by reference to Exhibit 21.1 of the Company&#8217;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 31, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex5-1.htm" STYLE="-sec-extract: exhibit">Consent of Dickinson Wright PLLC (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><A HREF="ex23-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of independent registered public accountant &#8211; Marcum LLP</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225002214/forms-1.htm#Ra_001" STYLE="-sec-extract: exhibit">Power of Attorney (contained in the signature page of this registration statement)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">101</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white; text-align: justify">Interactive Data File</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">104</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><P STYLE="margin: 0">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/890821/000149315225004213/ex107.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Filed herewith.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">**</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Previously filed.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">^</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets (&ldquo;[***]&rdquo;) because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">#</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Management contract or compensatory plan or arrangement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, we have duly caused this Registration Statement on Form S-1 to be signed
on its behalf by the undersigned, thereunto duly authorized in the City of Naples, Florida, on January 30, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Enveric Biosciences, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Joseph
    Tucker</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Tucker, Ph. D</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons
in the capacities and on the dates indicated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Joseph Tucker</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Tucker, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director (Principal Executive
    Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Kevin Coveney</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin Coveney</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer (Principal Financial Officer
    and Principal Accounting Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Facchini, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Innovation Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">George Kegler</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank Pasqualone</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Webb</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director (Chairman)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcus Schabacker, M.D.,
    Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sheila DeWitt, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 30, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 3%">*By:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <I>/s/ Joseph Tucker</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Tucker, Ph.D</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-fact</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>















</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex1-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Execution
Version</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
8, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STRICTLY
CONFIDENTIAL</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enveric
Biosciences, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4851
Tamiami Trail N, Suite 200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naples,
Florida 34103</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Joseph Tucker, Ph.D., Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Dr. Tucker:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter agreement (this &ldquo;<U>Agreement</U>&rdquo;) constitutes the agreement between Enveric Biosciences, Inc. (the &ldquo;<U>Company</U>&rdquo;)
and H.C. Wainwright &amp; Co., LLC (&ldquo;<U>Wainwright</U>&rdquo;), that Wainwright shall serve as the exclusive underwriter, agent
or advisor in any offering of securities of the Company (the &ldquo;<U>Securities</U>&rdquo;) during the Term (as hereinafter defined)
of this Agreement, including, but not limited to, a so-called at-the-market facility (&ldquo;<U>ATM</U>&rdquo;) (each, an &ldquo;<U>Offering</U>&rdquo;).
The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright
and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the
Company shall have an obligation to issue any Securities. It is understood that Wainwright&rsquo;s assistance in an Offering will be
subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate
under the circumstances and to the receipt of all internal approvals of Wainwright in connection with an Offering. The Company expressly
acknowledges and agrees that Wainwright&rsquo;s involvement in an Offering is strictly on a reasonable best efforts basis and that the
consummation of an Offering will be subject to, among other things, market conditions. The execution of this Agreement does not constitute
a commitment by Wainwright to purchase the Securities and does not ensure a successful Offering of the Securities or the success of Wainwright
with respect to securing any other financing on behalf of the Company. Wainwright may retain other underwriters, brokers, dealers or
agents on its behalf in connection with an Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. <U>Compensation;
Reimbursement</U>. The Company shall compensate Wainwright, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
                                            Fee</I>. The Company shall pay to Wainwright a cash fee, or as to an underwritten Offering
                                            an underwriter discount, equal to 7.0% of the aggregate gross proceeds raised at each closing
                                            of each Offering (each, a &ldquo;<U>Closing</U>&rdquo;); provided, however, that the cash
                                            fee for an ATM shall equal 3.0% of the aggregate gross proceeds raised in each takedown pursuant
                                            to an ATM.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 100%">430 Park Avenue | New York, New York 10022 | 212.356.0500 | www.hcwco.com</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center">Member: FINRA/SIPC</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Warrant
                                            Coverage</I>. The Company shall issue to Wainwright or its designees at each Closing, warrants
                                            (the &ldquo;<U>Wainwright Warrants</U>&rdquo;) to purchase that number of shares of common
                                            stock of the Company equal to 7.0% of the aggregate number of shares of common stock (or
                                            common stock equivalent, if applicable) placed in each Offering (and if an Offering includes
                                            a &ldquo;greenshoe&rdquo; or &ldquo;additional investment&rdquo; component, such number of
                                            shares of common stock underlying such &ldquo;greenshoe&rdquo; or &ldquo;additional investment&rdquo;
                                            component, with the Wainwright Warrants issuable upon the exercise of such component); provided,
                                            however, that no warrants will be issued to Wainwright in connection with an ATM. If the
                                            Securities included in an Offering are convertible, the Wainwright Warrants shall be determined
                                            by dividing the gross proceeds raised in such Offering by the Offering Price (as defined
                                            hereunder). The Wainwright Warrants shall be in a customary form reasonably acceptable to
                                            Wainwright, have a term of five (5) years and an exercise price equal to 125% of the offering
                                            price per share (or unit, if applicable) in the applicable Offering and if such offering
                                            price is not available, the market price of the common stock on the date an Offering is commenced
                                            (such price, the &ldquo;<U>Offering Price</U>&rdquo;). If warrants are issued to investors
                                            in an Offering, the Wainwright Warrants shall have the same terms as the warrants issued
                                            to investors in the applicable Offering, except that such Wainwright Warrants shall have
                                            an exercise price equal to 125% of the Offering Price.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expense
                                            Allowance</I>. Out of the proceeds of each Closing, the Company also agrees to pay Wainwright
                                            (a) a management fee equal to 1.0% of the gross proceeds raised in each Offering; (b) $35,000
                                            for non-accountable expenses (to be increased to $50,000 in case a public Offering is contemplated
                                            or consummated); (c) up to $50,000 for fees and expenses of legal counsel and other out-of-pocket
                                            expenses (to be increased to $100,000 in case a public Offering is contemplated or consummated);
                                            plus the additional amount payable by the Company pursuant to Paragraph D.4 hereunder and,
                                            if applicable, the costs associated with the use of a third-party electronic road show service
                                            (such as NetRoadshow); provided, however, that such amounts in no way limit or impair the
                                            indemnification and contribution provisions of this Agreement.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                           <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Notwithstanding
anything to the contrary included in the preceding paragraph, in connection with an ATM, the Company shall pay Wainwright up to $100,000
for fees and expenses of its legal counsel in addition to any other out-of-pocket expenses that will be incurred by the Company and Wainwright
in connection with the set-up, execution, performance and maintenance of the ATM.</TD></TR>
                                                                                                                           </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tail</I>.
                                            Wainwright shall be entitled to compensation under clauses (1) and (2) hereunder, calculated
                                            in the manner set forth therein, with respect to any public or private offering or other
                                            financing or capital-raising transaction of any kind (&ldquo;Tail Financing&rdquo;) to the
                                            extent that such Tail Financing is provided to the Company directly or indirectly by investors
                                            whom Wainwright (i) had brought over-the-wall during the Term, with respect to an Offering
                                            other than a public Offering, or (ii) had contacted during the Term, with respect to a public
                                            Offering, in each case if such Tail Financing is consummated at any time within the 12-month
                                            period following the expiration or termination of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
                                            of First Refusal</I>. If, from the date hereof until the 12-month anniversary following consummation
                                            of each Offering (subject to FINRA Rule 5110(g)(6)(A)), the Company decides to raise funds
                                            by means of a public offering (including at-the-market facility) or a private placement or
                                            any other capital-raising financing of equity, equity-linked or debt securities using an
                                            underwriter or placement agent, Wainwright (or any affiliate designated by Wainwright) shall
                                            have the right to act as sole book-running manager, sole underwriter or sole placement agent
                                            for such financing. If Wainwright or one of its affiliates decides to accept any such engagement,
                                            the agreement governing such engagement will contain, among other things, provisions for
                                            customary fees for transactions of similar size and nature and the provisions of this Agreement,
                                            including indemnification, which are appropriate to such a transaction.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 58.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. <U>Term
and Termination of Engagement; Exclusivity</U>. The term of Wainwright&rsquo;s exclusive engagement will begin on the date hereof and
end ninety (90) days thereafter (the &ldquo;<U>Initial Term</U>&rdquo;); provided, however, that if an Offering is consummated within
the Initial Term, the term of this Agreement shall be extended by an additional ninety (90) day period (the &ldquo;<U>Extension Term</U>,&rdquo;
and together with the Initial Term, the &ldquo;<U>Term</U>&rdquo;). For clarity, the term &ldquo;Term&rdquo; shall mean the Initial Term
if there is no Extension Term. Notwithstanding anything to the contrary contained herein, the Company agrees that the provisions relating
to the payment of fees, reimbursement of expenses, right of first refusal, tail, indemnification and contribution, confidentiality, conflicts,
independent contractor and waiver of the right to trial by jury will survive any termination or expiration of this Agreement. Notwithstanding
anything to the contrary contained herein, the Company has the right to terminate the Agreement for cause in compliance with FINRA Rule
5110(g)(5)(B)(i). The exercise of such right of termination for cause eliminates the Company&rsquo;s obligations with respect to the
provisions relating to the tail fees and right of first refusal. Notwithstanding anything to the contrary contained in this Agreement,
in the event that an Offering pursuant to this Agreement shall not be carried out for any reason whatsoever during the Term, the Company
shall be obligated to pay to Wainwright its actual and accountable out-of-pocket expenses related to an Offering (including the fees
and disbursements of Wainwright&rsquo;s legal counsel) and, if applicable, for electronic road show service used in connection with an
Offering subject to the cap limitations in Section A.3 hereof. During Wainwright&rsquo;s engagement hereunder: (i) the Company will not,
and will not permit its representatives to, other than in coordination with Wainwright, contact or solicit institutions, corporations
or other entities or individuals as potential purchasers of the Securities or investment banks in connection with an Offering and (ii)
the Company will not pursue any financing transaction which would be in lieu of an Offering. Furthermore, the Company agrees that during
Wainwright&rsquo;s engagement hereunder, all inquiries from prospective investors will be referred to Wainwright. Additionally, except
as set forth hereunder, the Company represents, warrants and covenants that no brokerage or finder&rsquo;s fees or commissions are or
will be payable by the Company or any subsidiary of the Company to any broker, financial advisor or consultant, finder, placement agent,
investment banker, bank or other third-party with respect to any Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C. <U>Information;
Reliance</U>. The Company shall furnish, or cause to be furnished, to Wainwright all information requested by Wainwright for the purpose
of rendering services hereunder and conducting due diligence (all such information being the &ldquo;<U>Information</U>&rdquo;). In addition,
the Company agrees to make available to Wainwright upon request from time to time the officers, directors, accountants, counsel and other
advisors of the Company. The Company recognizes and confirms that Wainwright (a) will use and rely on the Information, including any
documents provided to investors in each Offering (the &ldquo;<U>Offering Documents</U>&rdquo;) which shall include any Purchase Agreement
(as defined hereunder), and on information available from generally recognized public sources in performing the services contemplated
by this Agreement without having independently verified the same; (b) does not assume responsibility for the accuracy or completeness
of the Offering Documents or the Information and such other information; and (c) will not make an appraisal of any of the assets or liabilities
of the Company. Upon reasonable request, the Company will meet with Wainwright or its representatives to discuss all information relevant
for disclosure in the Offering Documents and will cooperate in any investigation undertaken by Wainwright thereof, including any document
included or incorporated by reference therein. At each Offering, at the request of Wainwright, the Company shall deliver such legal letters
(including, without limitation, negative assurance letters), opinions, comfort letters, officers&rsquo; and secretary certificates and
good standing certificates, all in form and substance satisfactory to Wainwright and its counsel as is customary for such Offering. Wainwright
shall be a third party beneficiary of any representations, warranties, covenants, closing conditions and closing deliverables made by
the Company in any Offering Documents, including representations, warranties, covenants, closing conditions and closing deliverables
made to any investor in an Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D. <U>Related
Agreements</U>. At each Offering, the Company shall enter into the following additional agreements, as applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Underwritten
                                            Offering</I>. If an Offering is an underwritten Offering, the Company and Wainwright shall
                                            enter into a customary underwriting agreement in form and substance satisfactory to Wainwright
                                            and its counsel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Best
                                            Efforts Offering</I>. If an Offering is on a best efforts basis, the sale of Securities to
                                            the investors in the Offering will be evidenced by a purchase agreement (&ldquo;<U>Purchase
                                            Agreement</U>&rdquo;) between the Company and such investors in a form reasonably satisfactory
                                            to the Company and Wainwright. Wainwright shall be a third party beneficiary with respect
                                            to the representations, warranties, covenants, closing conditions and closing deliverables
                                            included in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers
                                            of the Company with responsibility for financial affairs will be available to answer inquiries
                                            from prospective investors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ATM
                                            Offering</I>. If an Offering is an ATM, the Company and Wainwright shall enter into a customary
                                            at-the-market sales agreement in form and substance satisfactory to Wainwright and its counsel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Escrow,
                                            Settlement and Closing</I>. If each Offering is not settled via delivery versus payment (&ldquo;<U>DVP</U>&rdquo;),
                                            the Company and Wainwright shall enter into an escrow agreement with a third party escrow
                                            agent pursuant to which Wainwright&rsquo;s compensation and expenses shall be paid from the
                                            gross proceeds of the Securities sold. If the Offering is settled in whole or in part via
                                            DVP, Wainwright shall arrange for its clearing agent to provide the funds to facilitate such
                                            settlement; provided, however, if the clearing firm provides the funds in a best efforts
                                            offering and subsequent to such delivery an investor fails to provide the necessary funds
                                            to the clearing agent for such purchase of Securities, Wainwright shall instruct the clearing
                                            agent to promptly return any such Securities to the Company and the Company shall promptly
                                            return such investor&rsquo;s purchase price to the clearing agent. The Company shall pay
                                            Wainwright closing costs, which shall also include the reimbursement of the out-of-pocket
                                            cost of the escrow agent or clearing agent, as applicable, which closing costs shall not
                                            exceed $15,950.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FINRA
                                            Amendments</I>. Notwithstanding anything herein to the contrary, in the event that Wainwright
                                            determines that any of the terms provided for hereunder shall not comply with a FINRA rule,
                                            including but not limited to FINRA Rule 5110, then the Company shall agree to amend this
                                            Agreement (or include such revisions in the final underwriting agreement) in writing upon
                                            the request of Wainwright to comply with any such rules; provided that any such amendments
                                            shall not provide for terms that are less favorable to the Company than are reflected in
                                            this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E. <U>Confidentiality</U>.
In the event of the consummation or public announcement of any Offering, Wainwright shall have the right to disclose its participation
in such Offering, including, without limitation, the Offering at its cost of &ldquo;tombstone&rdquo; advertisements in financial and
other newspapers and journals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F. <U>Indemnity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            connection with the Company&rsquo;s engagement of Wainwright hereunder, the Company hereby
                                            agrees to indemnify and hold harmless Wainwright and its affiliates, and the respective controlling
                                            persons, directors, officers, members, shareholders, agents and employees of any of the foregoing
                                            (collectively the &ldquo;<U>Indemnified Persons</U>&rdquo;), from and against any and all
                                            claims, actions, suits, proceedings (including those of shareholders), damages, liabilities
                                            and expenses incurred by any of them (including the reasonable fees and expenses of counsel),
                                            as incurred, whether or not the Company is a party thereto (collectively a &ldquo;<U>Claim</U>&rdquo;),
                                            that are (A) related to or arise out of (i) any actions taken or omitted to be taken (including
                                            any untrue statements made or any statements omitted to be made) by the Company, or (ii)
                                            any actions taken or omitted to be taken by any Indemnified Person in connection with the
                                            Company&rsquo;s engagement of Wainwright, or (B) otherwise relate to or arise out of Wainwright&rsquo;s
                                            activities on the Company&rsquo;s behalf under Wainwright&rsquo;s engagement, and the Company
                                            shall reimburse any Indemnified Person for all expenses (including the reasonable fees and
                                            expenses of counsel) as incurred by such Indemnified Person in connection with investigating,
                                            preparing or defending any such claim, action, suit or proceeding, whether or not in connection
                                            with pending or threatened litigation in which any Indemnified Person is a party. The Company
                                            will not, however, be responsible for any Claim that is finally judicially determined to
                                            have resulted from the gross negligence or willful misconduct of any such Indemnified Person
                                            for such Claim. The Company further agrees that no Indemnified Person shall have any liability
                                            to the Company for or in connection with the Company&rsquo;s engagement of Wainwright except
                                            for any Claim incurred by the Company as a result of such Indemnified Person&rsquo;s gross
                                            negligence or willful misconduct.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company further agrees that it will not, without the prior written consent of Wainwright,
                                            settle, compromise or consent to the entry of any judgment in any pending or threatened Claim
                                            in respect of which indemnification may be sought hereunder (whether or not any Indemnified
                                            Person is an actual or potential party to such Claim), unless such settlement, compromise
                                            or consent includes an unconditional, irrevocable release of each Indemnified Person from
                                            any and all liability arising out of such Claim.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
                                            upon receipt by an Indemnified Person of notice of any complaint or the assertion or institution
                                            of any Claim with respect to which indemnification is being sought hereunder, such Indemnified
                                            Person shall notify the Company in writing of such complaint or of such assertion or institution
                                            but failure to so notify the Company shall not relieve the Company from any obligation it
                                            may have hereunder, except and only to the extent such failure results in the forfeiture
                                            by the Company of substantial rights and defenses. If the Company is requested by such Indemnified
                                            Person, the Company will assume the defense of such Claim, including the employment of counsel
                                            for such Indemnified Person and the payment of the fees and expenses of such counsel, provided,
                                            however, that such counsel shall be satisfactory to the Indemnified Person and provided further
                                            that if the legal counsel to such Indemnified Person reasonably determines that the use of
                                            counsel chosen by the Company to represent such Indemnified Person would present such counsel
                                            with a conflict of interest or if the defendant in, or target of, any such Claim, includes
                                            an Indemnified Person and the Company, and legal counsel to such Indemnified Person reasonably
                                            concludes that there may be legal defenses available to it or other Indemnified Persons different
                                            from or in addition to those available to the Company, such Indemnified Person will employ
                                            its own separate counsel (including local counsel, if necessary) to represent or defend him,
                                            her or it in any such Claim and the Company shall pay the reasonable fees and expenses of
                                            such counsel. If such Indemnified Person does not request that the Company assume the defense
                                            of such Claim, such Indemnified Person will employ its own separate counsel (including local
                                            counsel, if necessary) to represent or defend him, her or it in any such Claim and the Company
                                            shall pay the reasonable fees and expenses of such counsel. Notwithstanding anything herein
                                            to the contrary, if the Company fails timely or diligently to defend, contest, or otherwise
                                            protect against any Claim, the relevant Indemnified Person shall have the right, but not
                                            the obligation, to defend, contest, compromise, settle, assert crossclaims, or counterclaims
                                            or otherwise protect against the same, and shall be fully indemnified by the Company therefor,
                                            including without limitation, for the reasonable fees and expenses of its counsel and all
                                            amounts paid as a result of such Claim or the compromise or settlement thereof. In addition,
                                            with respect to any Claim in which the Company assumes the defense, the Indemnified Person
                                            shall have the right to participate in such Claim and to retain his, her or its own counsel
                                            therefor at his, her or its own expense.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company agrees that if any indemnity sought by an Indemnified Person hereunder is held by
                                            a court to be unavailable for any reason then (whether or not Wainwright is the Indemnified
                                            Person), the Company and Wainwright shall contribute to the Claim for which such indemnity
                                            is held unavailable in such proportion as is appropriate to reflect the relative benefits
                                            to the Company, on the one hand, and Wainwright on the other, in connection with Wainwright&rsquo;s
                                            engagement referred to above, subject to the limitation that in no event shall the amount
                                            of Wainwright&rsquo;s contribution to such Claim exceed the amount of fees actually received
                                            by Wainwright from the Company pursuant to Wainwright&rsquo;s engagement. The Company hereby
                                            agrees that the relative benefits to the Company, on the one hand, and Wainwright on the
                                            other, with respect to Wainwright&rsquo;s engagement shall be deemed to be in the same proportion
                                            as (a) the total value paid or proposed to be paid or received by the Company pursuant to
                                            the applicable Offering (whether or not consummated) for which Wainwright is engaged to render
                                            services bears to (b) the fee paid or proposed to be paid to Wainwright in connection with
                                            such engagement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&rsquo;s indemnity, reimbursement and contribution obligations under this Agreement
                                            (a) shall be in addition to, and shall in no way limit or otherwise adversely affect any
                                            rights that any Indemnified Person may have at law or at equity and (b) shall be effective
                                            whether or not the Company is at fault in any way.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.5pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G. <U>Limitation
of Engagement to the Company</U>. The Company acknowledges that Wainwright has been retained only by the Company, that Wainwright is
providing services hereunder as an independent contractor (and not in any fiduciary or agency capacity) and that the Company&rsquo;s
engagement of Wainwright is not deemed to be on behalf of, and is not intended to confer rights upon, any shareholder, owner or partner
of the Company or any other person not a party hereto as against Wainwright or any of its affiliates, or any of its or their respective
officers, directors, controlling persons (within the meaning of Section 15 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;) or Section 20 of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;)), employees
or agents. Unless otherwise expressly agreed in writing by Wainwright, no one other than the Company is authorized to rely upon this
Agreement or any other statements or conduct of Wainwright, and no one other than the Company is intended to be a beneficiary of this
Agreement. The Company acknowledges that any recommendation or advice, written or oral, given by Wainwright to the Company in connection
with Wainwright&rsquo;s engagement is intended solely for the benefit and use of the Company&rsquo;s management and directors in considering
a possible Offering, and any such recommendation or advice is not on behalf of, and shall not confer any rights or remedies upon, any
other person or be used or relied upon for any other purpose. Wainwright shall not have the authority to make any commitment binding
on the Company. The Company, in its sole discretion, shall have the right to reject any investor introduced to it by Wainwright.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H. <U>Limitation
of Wainwright&rsquo;s Liability to the Company</U>. Wainwright and the Company further agree that neither Wainwright nor any of its affiliates
or any of its or their respective officers, directors, controlling persons (within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act), employees or agents shall have any liability to the Company, its security holders or creditors, or any
person asserting claims on behalf of or in the right of the Company (whether direct or indirect, in contract, tort, for an act of negligence
or otherwise) for any losses, fees, damages, liabilities, costs, expenses or equitable relief arising out of or relating to this Agreement
or the services rendered hereunder, except for losses, fees, damages, liabilities, costs or expenses that arise out of or are based on
any action of or failure to act by Wainwright and that are finally judicially determined to have resulted solely from the gross negligence
or willful misconduct of Wainwright.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I. <U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements
made and to be fully performed therein. Any disputes that arise under this Agreement, even after the termination of this Agreement, will
be heard only in the state or federal courts located in the City of New York, State of New York. The parties hereto expressly agree to
submit themselves to the jurisdiction of the foregoing courts in the City of New York, State of New York. The parties hereto expressly
waive any rights they may have to contest the jurisdiction, venue or authority of any court sitting in the City and State of New York.
In the event Wainwright or any Indemnified Person is successful in any action, or suit against the Company, arising out of or relating
to this Agreement, the final judgment or award entered shall be entitled to have and recover from the Company the costs and expenses
incurred in connection therewith, including its reasonable attorneys&rsquo; fees. Any rights to trial by jury with respect to any such
action, proceeding or suit are hereby waived by Wainwright and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J. <U>Notices</U>.
All notices hereunder will be in writing and sent by certified mail, hand delivery, overnight delivery or e-mail, if sent to Wainwright,
at the address set forth on the first page hereof, e-mail: notices@hcwco.com, Attention: Head of Investment Banking, and if sent to the
Company, to the address set forth on the first page hereof, e-mail: jtucker@enveric.com, Attention: Chief Executive Officer. Notices
sent by certified mail shall be deemed received five days thereafter, notices sent by hand delivery or overnight delivery shall be deemed
received on the date of the relevant written record of receipt, notices sent by e-mail shall be deemed received as of the date and time
they were sent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K. <U>Conflicts</U>.
The Company acknowledges that Wainwright and its affiliates may have and may continue to have investment banking and other relationships
with parties other than the Company pursuant to which Wainwright may acquire information of interest to the Company. Wainwright shall
have no obligation to disclose such information to the Company or to use such information in connection with any contemplated transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L. <U>Anti-Money
Laundering</U>. To help the United States government fight the funding of terrorism and money laundering, the federal laws of the United
States require all financial institutions to obtain, verify and record information that identifies each person with whom they do business.
This means Wainwright must ask the Company for certain identifying information, including a government-issued identification number (e.g.,
a U.S. taxpayer identification number) and such other information or documents that Wainwright considers appropriate to verify the Company&rsquo;s
identity, such as certified articles of incorporation, a government-issued business license, a partnership agreement or a trust instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M. <U>Miscellaneous</U>.
The Company represents and warrants that it has all requisite power and authority to enter into and carry out the terms and provisions
of this Agreement and the execution, delivery and performance of this Agreement does not breach or conflict with any agreement, document
or instrument to which it is a party or bound. Furthermore, the Company represents and warrants that no consent, permit, waiver, approval
or authorization of any third party in connection with the execution, delivery and performance by the Company of this Agreement or an
Offering, is required or has not been obtained. This Agreement shall not be modified or amended except in writing signed by Wainwright
and the Company. This Agreement shall be binding upon and inure to the benefit of both Wainwright and the Company and their respective
assigns, successors, and legal representatives. This Agreement constitutes the entire agreement of Wainwright and the Company with respect
to the subject matter hereof and supersedes any prior agreements with respect to the subject matter hereof; provided, however, that those
certain engagement letters, dated as of April 6, 2022 and July 11, 2022, by and between the Company and Wainwright shall govern the subject
matter thereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will
not affect such provision in any other respect, and the remainder of the Agreement shall remain in full force and effect. This Agreement
may be executed in counterparts (including electronic counterparts), each of which shall be deemed an original but all of which together
shall constitute one and the same instrument. Signatures to this Agreement transmitted by electronic mail in &ldquo;portable document
format&rdquo; (.pdf) form, or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document,
will have the same effect as physical delivery of the paper document bearing the original signature. The undersigned hereby consents
to receipt of this Agreement in electronic form and understands and agrees that this Agreement may be signed electronically. In the event
that any signature is delivered by electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000,
Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or otherwise
by electronic transmission evidencing an intent to sign this Agreement, such electronic mail or other electronic transmission shall create
a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution and
delivery of this Agreement by electronic mail or other electronic transmission is legal, valid and binding for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
acknowledgment that the foregoing correctly sets forth the understanding reached by Wainwright and the Company, please sign in the space
provided below, whereupon this letter shall constitute a binding Agreement as of the date indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.C. WAINWRIGHT &amp; CO., LLC</B></FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 238.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted and Agreed:</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Enveric Biosciences, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>3
<FILENAME>ex1-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt"><B>Exhibit 1.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><IMG SRC="ex1-2_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Execution
Version</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
14, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>STRICTLY
CONFIDENTIAL</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enveric
Biosciences, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4851
Tamiami Trail N, Suite 200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naples,
Florida 34103</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Joseph Tucker, Ph.D., Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 5.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Tucker:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to the engagement letter (the &ldquo;<U>Engagement Letter</U>&rdquo;), dated December 8, 2024, by and between Enveric Biosciences,
Inc. (the &ldquo;<U>Company</U>&rdquo;) and H.C. Wainwright &amp; Co., LLC (&ldquo;<U>Wainwright</U>&rdquo;), pursuant to which Wainwright
shall serve as the exclusive agent, advisor or underwriter in any Offering of Securities of the Company during the &ldquo;Term&rdquo;
(as defined in the Engagement Letter). Defined terms used herein but not defined herein shall have the meanings given to such terms in
the Engagement Letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Wainwright hereby agree, solely in connection with the Offering of the Company&rsquo;s equity securities contemplated by
the Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about the date hereof, to amend
and restate clause (b) of Paragraph A.3 of the Engagement Letter as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;(b)
$25,000 for non-accountable expenses;&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as expressly set forth above, all of the terms and conditions of the Engagement Letter shall continue in full force and effect after
the execution of this amendment and shall not be in any way changed, modified or superseded except as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
amendment shall be construed and enforced in accordance with the laws of the State of New York, without regards to conflicts of laws
principles. This amendment may be executed in two or more counterparts, each one of which shall be an original, with the same effect
as if the signatures thereto and hereto were upon the same instrument. Counterparts may be delivered via electronic mail (including any
electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and
Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed
to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Remainder
of page intentionally left blank</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
acknowledgment that the foregoing correctly sets forth the understanding reached by Wainwright and the Company, please sign in the space
provided below, whereupon this amendment shall constitute a binding agreement as of the date indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.C. WAINWRIGHT &amp; CO., LLC</B></FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted and Agreed:</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Enveric Biosciences, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We consent to the inclusion in this Registration Statement of Enveric Biosciences, Inc. on Amendment No. 1 to Form S-1 (File No. 333-284277)
of our report dated March 25, 2024, except for the matter added and described in Notes 1 and 12, as to which the date is January 30, 2025,
which includes an explanatory paragraph as to the Company&rsquo;s ability to continue as a going concern, with respect to our audits of
the consolidated financial statements of Enveric Biosciences, Inc. as of and for the years ended December 31, 2023 and 2022, which report
appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading
&ldquo;Experts&rdquo; in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Morristown,
New Jersey</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
30, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex1-1_001.jpg
<TEXT>
begin 644 ex1-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Q @4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^^Q0H4X4_
M3'7CMCZXR.W6LVX !YLP?<L1UZ'(XQU]NW85HA7*MDG)'&?7_(QR._X5_$;_
M ,%*?VJ?^"FVH?\ !6CQO^R-^QQ\9_BE9BZT;X7MX'^&?A0:+96&G?VY\,]"
M\0Z_J^MZWK_A^7^P?#T;L_B;QGXD\4RLB$^7$0H KV\ERC$9WBIX2,J4%&$J
MDI5)2C"-."<I3E)2BU&*3;DVDDFW:Y\KQ9Q%AN%\$L;BLJJ9TVU'EARWU=E=
MM-)?+OV9_;5D?['Y'_"C(_V/R/\ A7^9-\0?^"HG_!6[X3^-?%_P\^(O[6?Q
MU\*^-?!^KZEX;\6^%M>71+#4=#U,\\_\4Z!TP49201R#R"..'_!7_P#X*=33
M""']M3XVW%Q_SZXT8_D/^$<SS_\ 7X(K[I>#>;-76=<(-6334W9IJZ:>J::>
MEK_---_F3\<N'$TGD_%M]K>[HUIKII\_\TO]06W+J0!;1QCIM+#<>F<Y)/3&
M#5\*HR./FZKQ_G^=?YV'BW]JO_@MG^RY\6OV:/#O[3'QM^.7@#3_ (WZQX"\
M3>';/Q!=>#!_;_AG7?&7AY-=T77MOAS_ (I_Q&BZVB^-?"Q_XK/P6NN*I  "
MU_H@@E7-PQ.$C0DD]\ <_CZ'J,X[GX7B/AK$<-QRARS:CGE//(3G&5--1A".
MDKZ*UM=M-.]S]#X4XLPG%']K+^RIY&\CFH-3<7NFTU9)6T=UK^(_,);<;=@0
M,X[=\Y!Y/7U%!(:(Y 8#^[G(X Y^AY(YQGN.*^8/VE/"/Q_\8_#J^MOV:_CA
MIOP5^(FF#4;W2M5U[X<:3\1O"VMNFDRC2-'UO2=?&=$T$S>6LWB+PRR.5$I(
ME??$WXW?\$2_VLOVY?V\_#GQ(^-O[0/QH\&CP%\//'6K?"BS^%?@?X2:/X9'
MBG4X_!\.N/KNM^.)/-\1Z#)%_P )!H4L$?A>-HG:,AB@9JYJ.73Q65YIG,?9
M^RR%I55*4^>\[Q@J:2:7-)6U:6CML>GBLZP>#S;*,F>52YL^4FI*W+:*;?-M
M=))MOMJC^C$H'QO7D=\\?_K]>./6FNT*C MRP&._X<\>HZ=JXWQ+!KFJ:#JF
MD>'=;/A3Q#JMGJ-MI/BG^RM,U/\ L+4PI72-5.C:T1#K>T[2(G+0RE3&P4,)
M(_YG_@O^TY_P5(\<?\%1OBC_ ,$^?$'[4GPRD\(_!+2(_B9XD^)>D_LY^$!X
MG\6^ W/P^UG0=&;1CXF/AGP[KOB@>.1X:E==Q15>55>3&[++LOEFO]J2@H..
M0VJ24G)>XXQ]Z%E*[O)+6RWWMH9EG6#RK%91#%Y;*^?R<5)<KM)=)7T?=Z*Z
MMJGH?U4T45QNO>)-#\)Z-J_B/Q%JVG:+H&AZ3J>LZQJVJW T_3=/TO15W:WJ
M^K.VQ%2)06)96!4<X8D5Q'T)TJJH&W9@'/7]>P_S]*JR1L/N6RL..I';_@8_
M_5FOP_\ AO\ M5_MB?\ !1K5M8\0_L9:EX+_ &;?V1=)\0:QH^B_M1?$GP%-
M\1OBS\=;_0I6T+5=;^"GPJ\0-X8\-Z!X <B*!?%GBXRRW,L<KVMNB?:(T]^\
M0?LN?MZ:1I8O/ /_  4D\3:UXNMK-UMM*^,/[.'P'\0?#?7'4!\:POP_\,>#
M?%FB(V& DA\8,6;:$1@7*=L<N>%;PV-S.,9M:J5W+TDX;66^LK+>VJ7STLX6
M+BL7@,I>=QV3@XZ+^[SWO?IW>BO<_55LX&>3Z]OQZG/Y9_"E4#;D]#U_ \5^
M%G[+'_!3WXD:K^USX>_X)]_ME?L_77PS_:LUZV\4ZAH_C?X9WC^)/V?/B7X)
MT'P;KOC<^-/!VN:ZR>)=%/B4>'M8C7PM=123P/#N>4NGR?M_>0W$UI<0V=P;
M6XGMV6SNOLP86F1@$YP,Y(8)P01R.E<^/R_%99BE'%M6<4X\K4ERSORRBXMI
MJ2O9KIJ[.Z/1RW,<+FN$^MX-W3NK.-G=='MJNJ?XEKYU^4*N.?E)P3^O\_IQ
MBFJ NXHFP]"S\ 9_/(_^M7\M.G_M9_\ !2KX5_\ !6'X8_L#_M _M*_#J\^%
M/CNS/CWP?\5=*_9_\(^&=6^*_AA=&UW5]%\%AAXE;PUX=\1>*/$?A_7?#!>$
M.[>67@$LC+O]S_X+$?&;_@IA^P_\,O$_[57P#^._PZ\6?!^#Q#I.C^)OA7XM
M_9^T6\UGX5Z7K83P_HNO:+XWA\21R:[H2>(P@E_X2N- A\0JJC!V#U5PIC7C
M,IP2S2#EGT5*E>346I727.Z=HW<7&2@I.*LFKM(^??%6$^IYQC?[+FED#M*_
M+?2U[).ZLG?7S:>[/Z)%R.?( ![DX''OBG\'KM^G&?SR/Y#^M?SG?M5?M0?M
MH?#G_@GA^R;^TK\ OVG/!OC[XN_%>\^"WABRT+6?@9X6.F_M$^/OVC]9\/#0
MM"T'1M#\1!? &N^%8]9UAV$,TJ2/H4RW2)+O$OZ\^$/ _P"T(/V<+#P1XM^.
M.C+^T;/X.FL]5^-NC_"[P^^EZ+XZ(CD.LZ/\+G(\-ZSHWA]I4T".-Y2)8TCE
MN)(99)8TX,3EWU?"+%RS6+4FU;5M6WO&4$K>:>MU:^J7H8;.?K.+>#PF5RT5
MW)\J6NJVV?\ 3/K<B/R<<8)^AY&.3V'/]1SS296.'(Y7\^0.WT[?SK\&?^"2
M'QY_;Q_:<UC]H#XF_M)_&?P%XW^#/P\^*WCK]G_X4V/P^^#^C^#=,^+6K> M
M:70];^,RZV\@\10^'F*;(O#+,D0N&\2*6,GA95D_2K]MC]I?0OV2/V8/BY^T
M'J=LMW+X"\):K>>&](RN/%7CK6 -"\">#P#EB_BCQ5K.AP *05+>8>$K?$9=
MB\+FJRF2C*HFE)1E=*;M[J;4972DKIQNM;I--+? 9U@L9E']LQ=LG:YDVK^Z
MMVUVTMOKH?77G!1'QPV1D?YQWY]?S-"KS(O9N03U/M_7Z'BOQ[_X(O\ [:_B
MO]N']B;PCXW^)6LG7/C=\._$OB3X9_%VZ-KI6EZC>^)]#==9T?6FT./":"/%
M'A?7-!E2(JN]]Y#*"6C_ &$)(8'V'X\#J>OK^=<F/P^)RO&3P>+5I*4HRTLT
MXM23^::?9JS0\LS#"9OE.69O@W>$X\R?D[I_?^'SL)%C:/*VJG)^<X)],9QZ
M_P#USC%0GR@V1 2Q'3( [=CC_(Z>G\V/_!;+]K3]O+]@*R\!?&WX(?''P;?_
M  N^+/Q$'PT_X5MXT^$/@^_OO VJ3>$)]=T36- \<*R/KNC*?#^N27/_  EL
M:F-IT"RR$,5_;_X*^$/C1X>^#=KX=^,OQG?XF_%[4]*O[B[^)NG?#[1/!.DV
M6IZUI0C@71? ^ALZKHGAF>7]T/%),T["!)Y$8K''KB,FGA<JRK.7FE/V>?.U
M-PE)S;C:,E*+@E#E;:CRRE=+KK;FPN=83&9MF^3+*Y.60I-MJ+7O*ZY=[75O
MUL?3!M\JH##@^N/RR.1U'_U^CLA1NQST(STQZGGT'Z=.:_F=\6_\%$OVE/\
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MC#XL^ O"/C7P1;^!/'^J_#'Q'X?\?+HR:GI_B?0]&T#6]87;H3R#*IKD:%N
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MPN%O:R?W_@?S4?\ !Q1\'/%5A\)O@#^WU\)86@^)W[%_Q=\->);R[M?+:_\
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M8VZOT."JV!QF$S/.6DL[SR<9<5Q3E>-2*<5%*[M:#;5[MW;U9_+!_P $Z_\
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MOQG;3Z#X?>9_")F,S_TCWDLMI:7$L$/VB>"S+VUNO!8CC\#P!GJ , 5^#O\
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M?^RM(UCQ'JPT[11OE_LG0_#\4GB'7)"""4B24L?G("$E/48H$BZ(0>1PA/\
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M;BW*JRPQ_P#"6HAD?AO^"N?_  2R\2_MJCX<_'K]G7Q-:_#K]L/X WNFZO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex1-2_001.jpg
<TEXT>
begin 644 ex1-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Q @4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^^8*%!"C\
M,]?SSZFLFY)SD6@;W,N!CCI@CZ'_ .OFM50^,,><=>,CKZ9SCCO7\1?_  4H
M_:G_ ."FNH_\%:?&_P"R-^QU\9_BE9K=:/\ "U_!'PR\*#1;+3],_MSX9Z#X
M@U[5]:UO7_#TO]@^'HW:3Q-XS\2>*9616(BC8)BO7R?*,1G6*J87GI0482JR
MG4DXQ5.FFYU)/FC:$$FW)NR2;VM?YGBKB/"\+X*&-Q>53SOF:BE%1O=O17E&
M22=]]>O:Q_;1A/1/R;_Z]&%]$_)J_P R;X@?\%/_ /@K7\+/&GB[X=_$3]K#
MXY>$_&O@_5;_ ,-^+/#VO+HFGZCH>I$9P=OA[ [,A4E2O1AD$<>/^"OO_!3:
M:;[/!^VE\8KBXN<[;8+HISZ'GPXNT9Z'(&!G'I]XO";B.44UF>&<6HRC*'.T
MU))J49*+4HM--.+:::=W%IO\T?CCP]%I/*N*KMM6O#3_ !:^[\VN_DO]0J!B
MI -L%!SP9%)]>"3V_D2/2KNT<C'7J.>W-?YUWB[]JK_@MC^RY\6OV:?#O[2W
MQL^.'@"P^-^K^ _$OAVS\17/@M?[?\-:]XQ\/1Z]HNN!/#N= \2(FM1KXU\+
M-CQEX,CUU R[0JM_HA [2;@GA F<#C)7:,^G.?4=Z^"XBX;Q7#D<I;S2EG=/
M.H.473<N6,8Z.]XI1M9IVNN^J=ON>%.*\)Q1_:R_LJ>1RR224N9INUKW]VRM
M9/3?2_57D#PY&8 ,=3DX/';' Q]?UHED)4^:.!CTR.>.F3S^'O7S!^TKX1^/
MWC#X=WUM^S5\<=-^"GQ$TS^T;W2=6U[X<:1\1?"VMNFE2#1]&UK2-?&=#T$S
M!%E\1>%V1R@E.)&+Q-^-_P#P1)_:S_;D_;P\/_$OX[_M _&CP:O@'P+XZU;X
M4V?PH\#_  AT?PV-:U2/0H]:?6]8\<S>9X@B9%U[0FAC\+*L,C*SNJYD8<]#
M+YXK*\SSE>S]ED3C&IS2DI)S=J:@N5I\TERN[6VG4]O%9U@\'FN59.\K=\]Y
MG=6M[JO*Z\EK>VVWE_1B 3C<.G0Y_P /3BF,\2DC[/D#'&[!Y[D]1S_AT-<=
MXDAUS4]!U/2/#FMGPGXAU:TU*UTGQ5_9&F:E_86IHN-'U<Z-K8\G7"IV,(F8
MQ2X*%5!$D?\ ,Y\%_P!IO_@J1XT_X*C?%#_@GSXA_:E^&+^$O@GHZ?$SQ)\2
M](_9S\'CQ1XM\"2#X?ZUH.BMHW_"2GPSX=U_Q0/'/_"-RLNYE"O*JN_#++L
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M9)+?\_ZWO^'VF(0I^1%&/0GOGU)/7US2>2&(+HI/U(X^H.?R]:_)7P%\*_\
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M%MJFD:K:Z=>:/JNEWBW^GW^FZWATU9,!0R;"S@DL2IY8C<%Z:O,/I!\71O\
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M-:'SMX;\4*N/XF\(>+1'XTMU:6(+/U8;,L/4R?).'LWDHY+5P\IJI93="?\
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M9.WGOVU;=_VL_P#@H=^QC^Q%;%M0^'/P*OI?VY_VBY @.F[? Q_L'X%>"]:
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M;]4_U$S7ZVVE_K90Y7%)O^'6O?F:5K:K=W2T:N:YC]<_XB-E/U2W_))2O?\
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MFI:5H?C66/0@VN^(?#+2 1QJK*.%)"JAP&Q^X'_#N?\ 8 SD?L+?L@[O[O\
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MU_-CHOB(?M=_\'(6I^%?$A&H^"/^"?WP6U;4? OA^Z0#3+/QWKNB> !KGC+
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M3^TU\6?VM?VU_C1^R^]_^PS^T-\+O#_PO^+^F:TUQK/@_P")OB/^W?[?\9^
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MHU_G=_X-Y/B1KW[.?@[XC_LK_M!?!?\ :&^#?C_XH?'67QEX/U?Q=\!_B8/
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MHNJ:WJY\/^'-<\0ZJNF:.BR.=)T#0H9?$FMS*CAD3PY&[.WRL%!)KU>*TV=
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MKQM^S'\%_$'[5W@?3_ 'QSU#P?I]W\1_#NF7LE\;/5#*W]BZMK,/E1+H.O\
MB7P]]F\1^,/#0=U\(>+Y9H>0"S_:7DS?YV_XTAMY3U_]E_\ BJR=9/#_ %91
MBK;5+6>RC:Z6UNFUU=)-MOTL/EL\/BWB_P"T*DFU\'*[;]5L_P ?1K0M1=&_
MWV_D**6-2H;(QEB1TZ''I17.>B24444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
4 !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
